Keyphrases
Acute Coronary Syndrome
100%
Hyaluronic Acid
71%
Diabetic Foot Ulcer
70%
Platelet-rich Fibrin
69%
Pada
58%
ST-elevation Myocardial Infarction (STEMI)
53%
Percutaneous Coronary Intervention
49%
Myocardial Infarction Patients
46%
Indonesia
41%
High-sensitivity C-reactive Protein (hs-CRP)
37%
Jakarta
36%
Obese Women
35%
Indonesian
35%
COVID-19
34%
Advanced Platelet-rich Fibrin
34%
Interleukin-6
33%
Granulation Index
31%
Randomized Controlled Trial
30%
Left Ventricular Dysfunction
29%
Inflammation
29%
Human Cardiomyocytes
26%
Acute Myocardial Infarction
26%
Left Ventricular Mass
26%
Indonesian Version
26%
Curcumin
26%
Hypertension
25%
Meta-analysis
24%
Chronic Kidney Disease
23%
Cardiovascular Disease
22%
Placebo
21%
Post-percutaneous Coronary Intervention
21%
6-minute Walk Test (6MWT)
20%
Ulcer Patients
20%
Systematic Meta-analysis
20%
Stable Coronary Artery Disease
19%
Heart Tissue
19%
Stenosis
19%
Randomized Clinical Trial
18%
Coronary Patients
18%
Coronary Artery Disease
18%
Echocardiography
18%
Heart Failure
18%
Peripheral Blood Stem Cells
17%
Serum Levels
17%
Arteriovenous Fistula
17%
Balloon Angioplasty
17%
Vascular Endothelial Growth Factor
17%
Quality of Life Questionnaire
17%
Heart Failure Patients
17%
Graves' Disease
17%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
93%
Platelet-Rich Fibrin
62%
foot ulcer, diabetic
61%
Hyaluronic Acid
53%
Inflammation
43%
Coronavirinae
40%
Disease
36%
Ischemic Heart Disease
33%
Heart Infarction
29%
Clopidogrel
26%
Acute Heart Infarction
26%
Heart Arrhythmia
26%
Graves Disease
26%
Wound
24%
Cross-Sectional Study
23%
Heart Failure
22%
C Reactive Protein
21%
Randomized Controlled Trial
20%
Cardiovascular Disease
20%
Congestive Heart Failure
20%
Stenosis
19%
Cardiovascular Disease
18%
Infarction
18%
Interleukin 6
17%
Tumor Necrosis Factor
17%
Systemic Lupus Erythematosus
17%
Curcumin
17%
Randomized Clinical Trial
17%
Wound Healing
16%
Placebo
15%
Propylthiouracil
15%
Granulocyte Colony Stimulating Factor
14%
Anticoagulant Agent
13%
Heart Right Ventricle Hypertrophy
13%
Proteinase
13%
Combination Therapy
13%
Antithyroid Agent
12%
Diabetes Mellitus
12%
Adult Respiratory Distress Syndrome
11%
Atherosclerosis
11%
Cytokine
11%
Methimazole
11%
Acetylsalicylic Acid
11%
Thrombocytopenia
11%
Chronic Kidney Failure
11%
Atrial Fibrillation
10%
Cohort Study
9%
Mortality Rate
9%
Chronic Inflammation
8%
In-Stent Restenosis
8%
Medicine and Dentistry
Platelet-Rich Fibrin
71%
Diabetic Foot Ulcer
71%
Restylane
62%
ST Segment Elevation Myocardial Infarction
44%
COVID-19
35%
Cardiovascular Disease
32%
Percutaneous Coronary Intervention
32%
Heart Failure
31%
Chronic Kidney Disease
31%
Congestive Heart Failure
27%
Left Ventricular Diastolic Dysfunction
27%
Randomized Controlled Trial
24%
Interleukin-6
23%
Stenosis
23%
Placebo
23%
Quality of Life
22%
Echocardiography
22%
Wound
21%
Major Adverse Cardiac Event
21%
Acute Coronary Syndrome
19%
Cohort Analysis
19%
Meta-Analysis
17%
Systemic Lupus Erythematosus
17%
Percutaneous Transluminal Angioplasty
17%
Cardiac Muscle Cell
17%
Acute Heart Infarction
17%
Arteriovenous Fistula
17%
Ischemic Heart Disease
17%
Cardiovascular System
17%
Wound Healing
17%
Heart Left Ventricle Ejection Fraction
16%
Myocardial Infarction
15%
Ejection Fraction
15%
Acute Coronary Syndrome
14%
Vasculotropin
14%
Angiogenesis
14%
Disease
13%
Cross Sectional Study
13%
Prevalence
12%
Platelet Derived Growth Factor
11%
Systolic Function
11%
Outpatient
11%
Maturity Onset Diabetes of the Young
11%
Diastolic Dysfunction
11%
Heart Left Ventricle Function
10%
Heart Tissue
10%
Diagnostic Accuracy
10%
Coronavirinae
9%
Systematic Review
9%
Hemodialysis
9%
